Darwin Global Management, Ltd. Portfolio Holdings

Darwin Global Management, Ltd.

  • $1.23 Billion
  • Q3 2024

Darwin Global Management, Ltd. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.23 Billion distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $766M, Vaxcyte, Inc. with a value of $251M, Geron Corp with a value of $100M, Keros Therapeutics, Inc. with a value of $88.5M, and Summit Therapeutics Inc. with a value of $23.8M.

Examining the 13F form we can see an increase of $403M in the current position value, from $827M to 1.23B.

Darwin Global Management, Ltd. is based out at St. Helier, Y9

Below you can find more details about Darwin Global Management, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $1.23 Billion
Healthcare: $1.23 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.42B
$251 Million 20.41% of portfolio
2,198,187
Q3 2024 Added 5.63%
$3.86B
$23.8 Million 1.93% of portfolio
1,084,880
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $1.23 Billion
  • Prior Value $827 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email